Amid University-wide budget cuts and closures of diversity-related programs, the University will sunset the Diversifying Academia, Recruiting Excellence (DARE) Doctoral Fellowship Program by the end ...
Hosted on MSN
Daré Bioscience targets Q4 2025 launch for DARE to PLAY Sildenafil cream while advancing dual-path strategy
Johnson reiterated the targeted Q4 2025 launch for DARE to PLAY Sildenafil cream through a 503B outsourcing facility. She stated, "We remain on track to support a fourth quarter 2025 launch." ...
Welcome to the conference call hosted by Daré Bioscience to review the company's third quarter 2025 financial results and to provide a business update. This call is being recorded. My name is [Jericho ...
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.55. Operator: Welcome to the conference call hosted by Daré Bioscience Therapeutics Company’s Second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results